The decline in cancer diagnoses during the COVID-19 shutdown in 2020 did not lead to an expected compensatory increase in diagnoses in 2021, according to NCI researchers.
Those least likely to schedule further screening mammograms had received a false-positive with recommendation for follow-up after only a short interval.